Clinical trial
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
NCT07403188
Study timeline
Study start (actual)2025-11-24Date precision: day
Registry last updated2026-02-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Refractory Lupus Nephritisunresolved
Myasthaenia Gravisunresolved
Stiff Person Syndromeunresolved
Rheumatoid Arthritis (RA)unresolved
Multiple Sclerosisunresolved
Dermatomyositisunresolved
Systemic Sclerosis (SSc)unresolved
Interventions
KYV-101DRUG
Sponsors & collaborators
Kyverna Therapeuticslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07403188 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.